Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide

Clinical and Experimental Metastasis

Volumn 16, Issue 2, 1998, Pages 179-183

  Ishiguro, Tatsuaki ^a   Naito, Mikihiko ^a   Hanaoka, Kenji ^a   Nagawa, Hirokazu ^a   Muto, Tetsuichiro ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Antisense oligonucleotide; B16 melanoma; Metastasis; TI 241

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INVASION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; LUNG METASTASIS; MELANOMA; METASTASIS POTENTIAL; MOLECULAR CLONING; MOUSE; NONHUMAN; ONCOGENE C FOS;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; DNA-BINDING PROTEINS; LEUCINE ZIPPERS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; TUMOR CELLS, CULTURED;

EID: 0031775796     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006528422244     Document Type: Article

References (14)

1. Fidler IJ, 1973, Selection of successive tumor lines for metastasis. Nat New Biol, 242, 148-9.
2. Poste G, Doll J, Hart IR and Fidler IJ, 1988, In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res, 40, 1636-44.
3. Ishiguro T, Nakajima M, Naito M, Muto T and Tsuruo T, 1996, Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res, 56, 875-9.
4. Hsu JC, Laz T, Mohn KL and Taub R, 1991, Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. Proc Natl Acad Sci USA, 88, 3511-15.
5. Fidler IJ, 1990, Critical factors in the biology of human cancer metastasis: 28th G. H. A. Clowes Memorial Award Lecture. Cancer Res, 50, 6130-8.
6. Nicolson GL, 1989, Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol, 1, 1009-19.
7. Hsu JC, Bravo R and Taub R, 1992, Interactions among LRF-1, Jun B, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol, 12, 4654-65.
8. Hsu JC, Cressman DE and Taub R, 1993, Promoter-specific trans-activation and inhibition mediated by Jun B. Cancer Res, 53, 3789-94.
9. Yamit-Hezi A, Plaksin D and Eisenbach L, 1994, c-fos and c-jun overexpression in malignant cells reduced their tumorigenic and metastatic potential, and affects their MHC class I gene expression. Oncogene, 9, 1065-79.
10. Rutberg SE, Goldstein IM, Yang YM, Stackpole CW and Ronai Z, 1994, Expression and transcriptional activity of AP-1, CRE, and URE binding proteins in B16 mouse melanoma sublines. Mol Carcinog, 10, 82-7.
11. Helene C and Toulme J-J, 1990, Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta, 1049, 99-125.
12. Williard R, Benz CC, Baxter JD, Kushner P and Hunt CA, 1994, Paradoxical production of target protein using antisense RNA expression vectors. Gene, 149, 21-4.
13. Tanaka T, Chu CC and Paul WE, 1992, An antisense oligonucleotide complementary to a sequence in I gamma 2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion. J Exp Med, 175, 597-607.
14. Jansen B, Wadl H, Inoue SA, et al. 1995, Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism. Antisense Res Dev, 5, 271-7.